Backed by a significant financial commitment of 3 billion FCFA, this crucial measure is scheduled to take effect on March 1, 2026, aiming to enhance equitable access to quality healthcare across the nation.

Following the Council of Ministers’ session held on February 12, 2026, Burkinabé authorities formally approved a substantial reduction in the cost of essential generic medicines, specific health products, and various medical consumables. These vital items are supplied through the Centrale d’achat des médicaments essentiels génériques (CAMEG). The implementation date for these new prices is set for March 1, 2026.

Dr Robert Lucien Jean-Claude Kargougou, the Minister of Health, elaborated on the tiered reductions, indicating diverse savings across different categories. Consumers can expect price drops of up to 67.27% on specific tablet forms, 53.47% on injectable products, and 20% on syrups and suspensions. Notably, certain medical consumables will see the most significant decrease, with prices falling by as much as 72.73%.

To ensure the successful rollout of this healthcare reform, the State is allocating an estimated 3 billion FCFA in financial backing. This strategic initiative is designed to alleviate the financial burden of healthcare expenses on households, enhance overall access to necessary medical treatments, and foster greater equity in the provision of healthcare services.

This latest round of price adjustments follows a similar reduction implemented in May 2025, which carried a budgetary impact estimated at nearly 5 billion FCFA. It underscores the Burkinabé authorities’ unwavering commitment to guaranteeing high-quality, accessible healthcare for all its citizens.